16.73USD-0.45%Mkt Cap: 1.77B USDP/E: 47.90Last update: 2026-05-26
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for …
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap1.77B USD
Enterprise Value2.18B USD
Revenue (TTM)2.18B USD
Gross Profit1.36B USD
Net Income (TTM)-713.41M USD
Revenue/Share21.41 USD
Last Price16.73 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees835
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS8036071004
Valuation
P/E (Trailing)47.90
P/E (Forward)6.22
PEG-0.09
EV/EBITDA47.30
EV/Revenue1.00
P/S0.82
P/B1.19
EPS (TTM)0.35
EPS (Forward)2.73
52W Range
10.4219% of range43.92
52W High43.92 USD
52W Low10.42 USD
Profitability
Gross Margin61.81%
Oper. Margin49.05%
EBITDA Margin2.11%
Profit Margin-32.45%
ROE-62.55%
ROA-21.30%
Growth
Revenue Growth-1.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-205.48M USD
CapEx (TTM)109.85M USD
FCF Margin9.38%
FCF Yield11.57%
Net Debt393.86M USD
Net Debt/EBITDA8.53
Balance Sheet
Debt/Equity0.91
Current Ratio4.63
Quick Ratio2.41
Book Value/Sh14.26 USD
Cash/Share6.187 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:6
Split DateJul 12, 2012
Analyst Consensus
Rating2.8 (Hold)
Target (Mean)22.00 USD
Target Range5.000 USD – 38.00 USD
# Analysts23
Ownership
Shares Out.105.58M
Float94.80M
Insiders4.09%
Institutions99.04%
Short Interest
Short Ratio10.1d
Short % Float28.29%
Short % Out.23.60%
Shares Short24.92M
Short (prev mo.)25.73M
Technical
SMA 5020.06 (-16.6%)
SMA 20019.98 (-16.3%)
Beta0.26
S&P 52W Chg28.31%
Avg Vol (30d)2.89M
Avg Vol (10d)3.18M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—